Top

Published in:

Open Access 01-01-2021 | Phlebothrombosis | Original Article

Genetic association study of fatal pulmonary embolism

Authors: Lisa Meißner, Peter Schürmann, Thilo Dörk, Lars Hagemeier, Michael Klintschar

Published in: International Journal of Legal Medicine | Issue 1/2021

Abstract

Pulmonary embolism (PE) is a complex multi-factorial disease and represents one manifestation of venous thromboembolism (VTE). Most commonly PE constitutes a complication of VTE’s other clinical presentation deep vein thrombosis (DVT). The majority of studies concerning risk factors do not distinguish between PE and DVT. The risk factors are often estimated to be alike, but the prevalence and the risk associated with the major genetic factor Factor V Leiden differ between the two disease states. We have investigated the association of 22 SNPs with PE in 185 PE case and 375 healthy control subjects. At p = 0.05, eight SNPs presented with nominally significant evidence of association (EOA), although no significantly different genotype distributions remained between cases and controls after Bonferroni correction. Three of these variants (rs1800790, rs3813948, rs6025) showed EOA in the main analysis, and five variants (rs169713, rs1801131, rs4524, rs5985 and rs8176592) demonstrated EOAs in subgroups. Genomic variation modulating Factor V, Factor XIII, Beta fibrinogen (FGB), TFPI or HIVEP1 should be worth to be followed in subsequent studies. The findings of this study support the view that PE represents a complex disease with many factors contributing relatively small effects. Larger sample sizes will be required to reliably detect these small effects.

Available only for authorised users

White RH (2003) The epidemiology of venous thromboembolism. Circulation 107:I4–I8. https://doi.org/10.1161/01.CIR.0000078468.11849.66CrossRefPubMed

Bĕlohlávek J, Dytrych V, Linhart A (2013) Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 18:129–138PubMedPubMedCentral

Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJB, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand J-P (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29:2276–2315. https://doi.org/10.1093/eurheartj/ehn310CrossRefPubMed

Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593CrossRef

Morange P-E, Trégouët D-A (2013) Current knowledge on the genetics of incident venous thrombosis. J Thromb Haemost 11(Suppl 1):111–121. https://doi.org/10.1111/jth.12233CrossRefPubMed

Ferrari E, Baudouy M, Cerboni P, Tibi T, Guigner A, Leonetti J, Bory M, Morand P (1997) Clinical epidemiology of venous thromboembolic disease: results of a French Multicentre Registry. Eur Heart J 18:685–691. https://doi.org/10.1093/oxfordjournals.eurheartj.a015316CrossRefPubMed

Goldhaber SZ, Visani L, de Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389CrossRef

Larsen TB, Sørensen HT, Skytthe A, Johnsen SP, Vaupel JW, Christensen K (2003) Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology 14:328–332PubMed

Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J (2000) Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101:1546–1551CrossRef

10.

Zöller B, Li X, Sundquist J, Sundquist K (2011) Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation 124:1012–1020. https://doi.org/10.1161/CIRCULATIONAHA.110.965020CrossRefPubMed

11.

Nicolaides AN, Breddin HK, Carpenter P, Coccheri S, Conard J, de Stefano V, Elkoofy N, Gerotziafas G, Guermazi S, Haas S, Hull R, Kalodiki E, Kristof V, Michiels JJ, Myers K, Pineo G, Prandoni P, Romeo G, Samama MM, Simonian S, Xenophonthos S (2005) Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol 24:1–26CrossRef

12.

Auro K, Alanne M, Kristiansson K, Silander K, Kuulasmaa K, Salomaa V, Peltonen L, Perola M (2007) Combined effects of thrombosis pathway gene variants predict cardiovascular events. PLoS Genet 3:e120. https://doi.org/10.1371/journal.pgen.0030120CrossRefPubMedPubMedCentral

13.

Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353:1167–1173CrossRef

14.

Trégouët D-A, Heath S, Saut N, Biron-Andreani C, Schved J-F, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi M-C, Tiret L, Lathrop M, Emmerich J, Morange P-E (2009) Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 113:5298–5303. https://doi.org/10.1182/blood-2008-11-190389CrossRefPubMed

15.

Uitte de Willige S, de Visser MCH, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM (2005) Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 106:4176–4183. https://doi.org/10.1182/blood-2005-05-2180CrossRefPubMed

16.

Germain M, Saut N, Greliche N, Dina C, Lambert J-C, Perret C, Cohen W, Oudot-Mellakh T, Antoni G, Alessi M-C, Zelenika D, Cambien F, Tiret L, Bertrand M, Dupuy A-M, Letenneur L, Lathrop M, Emmerich J, Amouyel P, Trégouët D-A, Morange P-E (2011) Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One 6:e25581. https://doi.org/10.1371/journal.pone.0025581CrossRefPubMedPubMedCentral

17.

Heit JA, Armasu SM, Asmann YW, Cunningham JM, Matsumoto ME, Petterson TM, de Andrade M (2012) A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost 10:1521–1531. https://doi.org/10.1111/j.1538-7836.2012.04810.xCrossRefPubMedPubMedCentral

18.

Tang W, Teichert M, Chasman DI, Heit JA, Morange P-E, Li G, Pankratz N, Leebeek FW, Paré G, de Andrade M, Tzourio C, Psaty BM, Basu S, Ruiter R, Rose L, Armasu SM, Lumley T, Heckbert SR, Uitterlinden AG, Lathrop M, Rice KM, Cushman M, Hofman A, Lambert J-C, Glazer NL, Pankow JS, Witteman JC, Amouyel P, Bis JC, Bovill EG, Kong X, Tracy RP, Boerwinkle E, Rotter JI, Trégouët D-A, Loth DW, Stricker BHC, Ridker PM, Folsom AR, Smith NL (2013) A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol 37:512–521. https://doi.org/10.1002/gepi.21731CrossRefPubMedPubMedCentral

19.

Desmarais S, de Moerloose P, Reber G, Minazio P, Bounameaux H, Perrier A (1996) Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 347:1374–1375. https://doi.org/10.1016/S0140-6736(96)91013-2CrossRefPubMed

20.

van Langevelde K, Flinterman LE, van Hylckama VA, Rosendaal FR, Cannegieter SC (2012) Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood 120:933–946. https://doi.org/10.1182/blood-2012-02-407551CrossRefPubMed

21.

Brandimarti F, Alessandrini F, Pesaresi M, Catalani C, de Angelis L, Galeazzi R, Giovagnetti S, Gesuita R, Righi E, Giorgetti R, Tagliabracci A (2017) Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism. Int J Legal Med 131:447–458. https://doi.org/10.1007/s00414-016-1508-zCrossRefPubMed

22.

Germain M, Chasman DI, de Haan H, Tang W, Lindström S, Weng LC, de Andrade M, de Visser MC, Wiggins KL, Suchon P, Saut N, Smadja DM, le Gal G, van Hylckama Vlieg A, di Narzo A, Hao K, Nelson CP, Rocanin-Arjo A, Folkersen L, Monajemi R, Rose LM, Brody JA, Slagboom E, Aïssi D, Gagnon F, Deleuze JF, Deloukas P, Tzourio C, Dartigues JF, Berr C, Taylor KD, Civelek M, Eriksson P, Cardiogenics Consortium, Psaty BM, Houwing-Duitermaat J, Goodall AH, Cambien F, Kraft P, Amouyel P, Samani NJ, Basu S, Ridker PM, Rosendaal FR, Kabrhel C, Folsom AR, Heit J, Reitsma PH, Trégouët DA, Smith NL, Morange PE (2015) Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet 96(4):532–542. https://doi.org/10.1016/j.ajhg.2015.01.019CrossRefPubMedPubMedCentral

23.

Sennblad B, Basu S, Mazur J, Suchon P, Martinez-Perez A, van Hylckama Vlieg A, Truong V, Li Y, Gådin JR, Tang W, Grossman V, de Haan HG, Handin N, Silveira A, Souto JC, Franco-Cereceda A, Morange P-E, Gagnon F, Soria JM, Eriksson P, Hamsten A, Maegdefessel L, Rosendaal FR, Wild P, Folsom AR, Trégouët D-A, Sabater-Lleal M (2017) Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels. Hum Mol Genet 26:637–649. https://doi.org/10.1093/hmg/ddw401CrossRefPubMedPubMedCentral

24.

Austin H, de Staercke C, Lally C, Bezemer ID, Rosendaal FR, Hooper WC (2011) New gene variants associated with venous thrombosis: a replication study in White and Black Americans. J Thromb Haemost 9:489–495. https://doi.org/10.1111/j.1538-7836.2011.04185.xCrossRefPubMedPubMedCentral

25.

De Haan HG, Bezemer ID, Doggen CJM, Le Cessie S, Reitsma PH, Arellano AR (2012) Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 120(3):656–663. https://doi.org/10.1182/blood-2011-12-397752CrossRefPubMed

26.

Morange PE, Bezemer I, Saut N, Bare L, Burgos G, Brocheton J, Durand H, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Germain M, Nicaud V, Heath S, Ninio E, Delluc A, Münzel T, Zeller T, Brand-Herrmann SM, Alessi MC, Tiret L, Lathrop M, Cambien F, Blankenberg S, Emmerich J, Trégouët DA, Rosendaal FR (2010) A follow-up study of agenome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet 86:592–595CrossRef

27.

Buil A, Trégouët D-A, Souto JC, Saut N, Germain M, Rotival M, Tiret L, Cambien F, Lathrop M, Zeller T, Alessi M-C, Rodriguez de Cordoba S, Münzel T, Wild P, Fontcuberta J, Gagnon F, Emmerich J, Almasy L, Blankenberg S, Soria J-M, Morange P-E (2010) C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood 115:4644–4650. https://doi.org/10.1182/blood-2010-01-263038CrossRefPubMedPubMedCentral

28.

Morange P-E, Saut N, Antoni G, Emmerich J, Trégouët D-A (2011) Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels. J Thromb Haemost 9:229–231. https://doi.org/10.1111/j.1538-7836.2010.04082.xCrossRefPubMed

29.

Hafke A, Schürmann P, Rothämel T, Dörk T, Klintschar M (2019) Evidence for an association of interferon gene variants with sudden infant death syndrome. Int J Legal Med 133(3):863–869. https://doi.org/10.1007/s00414-018-1974-6CrossRefPubMed

30.

Fluidigm Corporation (2016) SNP genotyping. Users Guide: PN 68000098 M2

31.

Hong EP, Park JW (2012) Sample size and statistical power calculation in genetic association studies. Genomics Inform 10:117–122. https://doi.org/10.5808/GI.2012.10.2.117CrossRefPubMedPubMedCentral

32.

Butler JM (2010) Fundamentals of forensic DNA typing. Academic Press/Elsevier, Amsterdam

33.

Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291. https://doi.org/10.1038/nature19057CrossRefPubMedPubMedCentral

34.

Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D (2002) The -33T--C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 88:195–199CrossRef

35.

Stein PD, Beemath A, Olson RE (2005) Obesity as a risk factor in venous thromboembolism. Am J Med 118:978–980. https://doi.org/10.1016/j.amjmed.2005.03.012CrossRefPubMed

36.

Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, Munafò MR (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365–376. https://doi.org/10.1038/nrn3475CrossRefPubMed

37.

Suresh K, Chandrashekara S (2012) Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci 5:7–13. https://doi.org/10.4103/0974-1208.97779CrossRefPubMedPubMedCentral

38.

Ziegler A, König IR, Pahlke F (2012) A statistical approach to genetic epidemiology: concepts and applications, with an e-learning platform, 4th edn. John Wiley & Sons, Weinheim

39.

van Stralen KJ, Doggen CJM, Bezemer ID, Pomp ER, Lisman T, Rosendaal FR (2008) Mechanisms of the factor V Leiden paradox. Arterioscler Thromb Vasc Biol 28:1872–1877. https://doi.org/10.1161/ATVBAHA.108.169524CrossRefPubMed

40.

Cushman M, Cornell A, Folsom AR, Wang L, Tsai MY, Polak J, Tang Z (2007) Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis. Thromb Res 121:339–345. https://doi.org/10.1016/j.thromres.2007.05.009CrossRefPubMedPubMedCentral

41.

Harrington DJ, Malefora A, Schmeleva V, Kapustin S, Papayan L, Blinov M, Harrington P, Mitchell M, Savidge GF (2003) Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis. Clin Chem Lab Med 41:496–500CrossRef

42.

Camilleri RS, Cohen H (2005) No association between pulmonary embolism or deep vein thrombosis and the –455G/A β-fibrinogen gene polymorphism. Blood Coagul Fibrinolysis 16:193–198. https://doi.org/10.1097/01.mbc.0000164428.13417.e2CrossRefPubMed

43.

Franco RF, Reitsma PH, Lourenço D, Maffei FH, Morelli V, Tavella MH, Araújo AG, Piccinato CE, Zago MA (1999) Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 81:676–679CrossRef

44.

Lincz LF, Adams MJ, Scorgie FE, Thom J, Baker RI, Seldon M (2007) Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden. Blood Coagul Fibrinolysis 18:559–564. https://doi.org/10.1097/MBC.0b013e3281eec977CrossRefPubMed

45.

Branchford BR, Carpenter SL (2018) The role of inflammation in venous thromboembolism. Front Pediatr 6:142CrossRef

46.

Liu F, Silva D, Malone MV, Seetharaman K (2017) MTHFR A1298C and C677T polymorphisms are associated with increased risk of venous thromboembolism: a retrospective chart review study. Acta Haematol 138:208–215. https://doi.org/10.1159/000480447CrossRefPubMed

47.

Li Z, Yadav U, Mahemuti A, Tang B-P, Upur H (2015) Association of MTHFR genetic polymorphisms with venous thromboembolism in Uyghur population in Xinjiang, China. Int J Clin Exp Med 8:17703–17711PubMedPubMedCentral

48.

Bezemer ID, Bare LA, Arellano AR, Reitsma PH, Rosendaal FR (2010) Updated analysis of gene variants associated with deep vein thrombosis. JAMA 303:421–422. https://doi.org/10.1001/jama.2010.57CrossRefPubMed

Title: Genetic association study of fatal pulmonary embolism
Authors: Lisa Meißner
Peter Schürmann
Thilo Dörk
Lars Hagemeier
Michael Klintschar
Publication date: 01-01-2021
Publisher: Springer Berlin Heidelberg
Keyword: Phlebothrombosis
Published in: International Journal of Legal Medicine / Issue 1/2021
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI: https://doi.org/10.1007/s00414-020-02441-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Genetic association study of fatal pulmonary embolism

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Be careful with lentils! About a forensic observation

Postmortem examination of three SARS-CoV-2-positive autopsies including histopathologic and immunohistochemical analysis

Exploration of the microbiome community for saliva, skin, and a mixture of both from a population living in Guangdong

Discrimination of highly degraded, aged Asian and African elephant ivory using denaturing gradient gel electrophoresis (DGGE)

Sharp force trauma with two katana swords: identifying the murder weapon by comparing tool marks on the skull bone

Ancestry and phenotype predictions from touch DNA using massively parallel sequencing